The COVAX Facility set up to ensure that COVID-19 vaccines got to the most vulnerable, no matter where they lived, was unprecedented, and evolved many times over the pandemic. Here are five key factors that led to one of the biggest emergency…

It’s a disease of the poor – but with drugs scarce in public facilities, patients are having to pay out of pocket for increasingly expensive medicines on the private market.

A warmer planet may bring less frequent, but stronger, hurricanes, prompting debate on adding a Category 6 to the current Saffir-Simpson scale.

The first death from Alaskapox virus marks a significant development since its discovery in 2015, but human-to-human transmission has not yet been observed.

Challenges and opportunities for improving equity and coverage among zero-dose and under-immunised children in four countries. 

Memes have featured in anti-vaccine messaging for centuries and their power to spread harmful health disinformation is growing.

Post-viral illnesses have often been neglected by science. Insights into Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) show that this is the time to ramp up efforts.

Though new vaccines often meet with parental wariness, health workers on the ground say mums and babies are turning out in force for the RTS,S jab.

As the arachnid expands northward, it’s bringing novel maladies, from a meat allergy to the Bourbon virus.

A new study examines why oral rehydration salts for diarrhoea are under-prescribed in India, and what to do about it.

Clinical trial participants are overwhelmingly white, meaning much of our medical data has a racial bias. Here’s how we can tackle racism in medicine.